124 related articles for article (PubMed ID: 1324044)
1. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
Torrent C; Wang P; Darlix JL
Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044
[TBL] [Abstract][Full Text] [Related]
2. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer.
Torrent C; Gabus C; Darlix JL
J Virol; 1994 Feb; 68(2):661-7. PubMed ID: 8289369
[TBL] [Abstract][Full Text] [Related]
3. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus.
Torrent C; Bordet T; Darlix JL
J Mol Biol; 1994 Jul; 240(5):434-44. PubMed ID: 8046749
[TBL] [Abstract][Full Text] [Related]
4. An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors.
Berlioz C; Torrent C; Darlix JL
J Virol; 1995 Oct; 69(10):6400-7. PubMed ID: 7666541
[TBL] [Abstract][Full Text] [Related]
5. Specific packaging of spliced retroviral vector transcripts lacking the Psi-region.
Pambalk K; Hohenadl C; Salmons B; Günzburg WH; Renner M
Biochem Biophys Res Commun; 2002 Apr; 293(1):239-46. PubMed ID: 12054590
[TBL] [Abstract][Full Text] [Related]
6. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy.
Chakraborty AK; Zink MA; Hodgson CP
Cancer Gene Ther; 1994 Jun; 1(2):113-8. PubMed ID: 7621242
[TBL] [Abstract][Full Text] [Related]
7. High efficiency retroviral vectors that contain no viral coding sequences.
Yu SS; Kim JM; Kim S
Gene Ther; 2000 May; 7(9):797-804. PubMed ID: 10822307
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus envelopes.
Kim T; Leibfried-Rutledge ML; First NL
Mol Reprod Dev; 1993 Jun; 35(2):105-13. PubMed ID: 8391277
[TBL] [Abstract][Full Text] [Related]
9. MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency.
Patience C; Takeuch Y; Cosset FL; Weiss RA
Dev Biol (Basel); 2001; 106():169-79; discussion 253-63. PubMed ID: 11761229
[TBL] [Abstract][Full Text] [Related]
10. Improved safety and titre of murine leukaemia virus (MLV)-based retroviral vectors.
Zhao Y; Low W; Collins MK
Gene Ther; 2000 Feb; 7(4):300-5. PubMed ID: 10694810
[TBL] [Abstract][Full Text] [Related]
11. Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses.
Hatzoglou M; Hodgson CP; Mularo F; Hanson RW
Hum Gene Ther; 1990; 1(4):385-97. PubMed ID: 1964095
[TBL] [Abstract][Full Text] [Related]
12. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary studies on the design of retroviral vectors for substitutive gene therapy].
Martín F; Jean-Mairet Y; Talavera A
Microbiologia; 1996 Mar; 12(1):43-50. PubMed ID: 9019133
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J
Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analyses of stability of simple and complex retroviral vectors.
Higashikawa F; Chang L
Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826
[TBL] [Abstract][Full Text] [Related]
16. The spread of a replication-competent MuLV retroviral vector can be efficiently blocked by deletion variants.
Nouvel P; Panthier JJ; Condamine H
Virology; 1994 Oct; 204(1):180-9. PubMed ID: 8091651
[TBL] [Abstract][Full Text] [Related]
17. In vitro testing of a potential retroviral vector for producing transgenic livestock.
Squire KR; Embretson JE; First NL
Am J Vet Res; 1989 Aug; 50(8):1423-7. PubMed ID: 2551203
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
19. Replication of enhancer-deficient amphotropic murine leukemia virus in human cells.
Reuss FU; Berdel B; Ploss M; Heber R
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10898-903. PubMed ID: 11535815
[TBL] [Abstract][Full Text] [Related]
20. Harvey sarcoma virus genome contains no extensive sequences unrelated to those of other retroviruses except ras.
Manly KF; Anderson GR; Stoler DL
J Virol; 1988 Sep; 62(9):3540-3. PubMed ID: 2841504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]